Takeda Pharmaceutical Company ...
TSE:4502
¥ 4,314.00
¥-38.00 (-0.87%)
¥ 4,314.00
¥-38.00 (-0.87%)
End-of-day quote: 03/11/2024

4502 - Takeda Pharmaceutical Company Stock Prediction 2025 - 2030

20 years of reliable Takeda Pharmaceutical Company stock forecast. The Wall Street analysts predict Outperform for 4502. See at a glance whether TSE:4502 will rise in the future.

Forecast 2023
Forecast 2025
Forecast 2030
Underperform
TopGraphs Quality Ranking
Forecast 2023
Forecast 2025
Forecast 2030
TopGraphs Quality Ranking
Underperform

Company Info

P/E
0.00
Beta
0.54
Price-to-book Ratio
1.00
Market Cap
6,768.30B
TEV
11,674.32 B
Dividend
¥186.36
Div Yld
4.32%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
¥4,740.53
Country

Takeda Pharmaceutical Company Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

Takeda Pharmaceutical Company Stock Forecast 2023

¥4,600.00

In the last five quarters, Takeda Pharmaceutical Company’s Price Target has risen from ¥4,561.71 to ¥4,740.53 - a 3.92% increase.

6.63%
6.63
Last update: 03/12/2024

Highest Price Target ¥5,800.00

Average Price Target ¥4,600.00

Lowest Price Target ¥4,200.00

Takeda Pharmaceutical Company Stock Prediction 2025

Takeda Pharmaceutical Company Stock Forecast 2030

P/E
0.00
Beta
0.54
Price-to-book Ratio
1.00
Market Cap
6,768.30B
TEV
11,674.32 B
Dividend
¥186.36
Div Yld
4.32%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
¥4,740.53
Country

Takeda Pharmaceutical Company Analyst Ratings Frequently Asked Questions

Who are the analysts watching Takeda Pharmaceutical Company Limited?

The following analysts have recently covered Takeda Pharmaceutical Company:

BofA Global Research
CFRA Equity Research
Citigroup Inc
Citigroup Inc. Research
Daiwa Securities Co. Ltd.
Goldman Sachs
J.P. Morgan
Jefferies LLC
Marktfeld
Mizuho Securities Co., Ltd.
Moody’s
Morgan Stanley
Morningstar Inc.
Nomura Securities Co. Ltd.
Pathology Associates Co., Ltd.
S&P Global Ratings
CLSA
Crisp Idea
Disclosure Insight
Macquarie Research
Sanford C. Bernstein & Co., LLC
SMBC NIKKO
TD Cowen
UBS Investment Bank
Aizawa Securities Co. Ltd.
Tokai Tokyo Intelligence Laboratory Co., Ltd.
(This information refers to the last 90 days.)

Who are the sell-side analysts watching Takeda Pharmaceutical Company Limited?

The following sell-side analysts have recently covered Takeda Pharmaceutical Company:

Yamaguchi, Hidemaru
Hashiguchi, Kazuaki
Ueda, Akinori
Barker, Stephen
Paraskevopoulos, Michail
Tanaka, Hiroshi
Muraoka, Shinichiro
Lee, Jay
Akahane, Takashi
Kumaar, Mohit
Büchner, Dion Stéfan
Endo, Shinichi
Mamegano, Koichi
Bahari, Hazim
Yan, Yonglin
Murarka, Rimi
Gavin, John P.
Wakao, Seiji
Ren, Tony
Matsubara, Hiroyuki
Sogi, Miki
Wada, Hiroshi
Nedelcovych, Michael Thomas
Haruta, Kasumi
Yokoyama, Yasushi
(This information refers to the last 90 days.)